Invivyd Valuation
| IVVD Stock | USD 0.81 0.01 1.25% |
Today, the firm appears to be overvalued. Invivyd retains a regular Real Value of $0.66 per share. The prevalent price of the firm is $0.81. Our model calculates the value of Invivyd from evaluating the firm fundamentals such as Shares Outstanding of 119.96 M, return on asset of -0.58, and Return On Equity of -1.23 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Invivyd's price fluctuation is out of control at this time. Calculation of the real value of Invivyd is based on 3 months time horizon. Increasing Invivyd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Invivyd stock is determined by what a typical buyer is willing to pay for full or partial control of Invivyd. Since Invivyd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Invivyd Stock. However, Invivyd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.81 | Real 0.66 | Hype 0.81 | Naive 0.79 |
The real value of Invivyd Stock, also known as its intrinsic value, is the underlying worth of Invivyd Company, which is reflected in its stock price. It is based on Invivyd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Invivyd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Invivyd helps investors to forecast how Invivyd stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Invivyd more accurately as focusing exclusively on Invivyd's fundamentals will not take into account other important factors: Invivyd Total Value Analysis
Invivyd is currently anticipated to have valuation of 48.79 M with market capitalization of 95.97 M, debt of 1.3 M, and cash on hands of 418.67 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Invivyd fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
48.79 M | 95.97 M | 1.3 M | 418.67 M |
Invivyd Investor Information
About 41.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. Invivyd recorded a loss per share of 1.19. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Invivyd's historical financial statements, Invivyd is not in a good financial situation at this time. It has a very high odds of going through financial crisis in August.Invivyd Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Invivyd has an asset utilization ratio of 19.6 percent. This indicates that the Company is making $0.2 for each dollar of assets. An increasing asset utilization means that Invivyd is more efficient with each dollar of assets it utilizes for everyday operations.Invivyd Ownership Allocation
Invivyd has a total of 119.96 Million outstanding shares. Over half of Invivyd's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Also note that almost eight million seven hundred thirty-three thousand one hundred sixty-one invesors are currently shorting Invivyd expressing very little confidence in its future performance.Invivyd Profitability Analysis
The company reported the previous year's revenue of 25.38 M. Net Loss for the year was (169.93 M) with profit before overhead, payroll, taxes, and interest of 34.24 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Invivyd's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Invivyd and how it compares across the competition.
About Invivyd Valuation
The stock valuation mechanism determines Invivyd's current worth on a weekly basis. Our valuation model uses a comparative analysis of Invivyd. We calculate exposure to Invivyd's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Invivyd's related companies.Invivyd, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Invivyd, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Invivyd operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Invivyd Growth Indicators
Investing in growth stocks can be very risky. If the company such as Invivyd does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 118.6 M | |
| Forward Price Earnings | 4.9068 |
Complementary Tools for Invivyd Stock analysis
When running Invivyd's price analysis, check to measure Invivyd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invivyd is operating at the current time. Most of Invivyd's value examination focuses on studying past and present price action to predict the probability of Invivyd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invivyd's price. Additionally, you may evaluate how the addition of Invivyd to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |